Seizures, Headache & SleepApril 17, 20266 min read

Everything You Need to Know About Status epilepticus for Step 1

Deep dive: definition, pathophysiology, clinical presentation, diagnosis, treatment, HY associations for Status epilepticus. Include First Aid cross-references.

Status epilepticus is one of those “don’t-miss” neurology emergencies that shows up everywhere—from ICU vignettes to Step 1 pharm questions about GABA-A. If you can define it precisely, recognize subtle presentations (especially nonconvulsive status), and run the treatment algorithm without hesitating, you’ll pick up easy points and—more importantly—learn a real-life lifesaving workflow.

What is Status Epilepticus? (Definition + Step-Friendly Timing)

Status epilepticus (SE) = continuous seizure activity or recurrent seizures without return to baseline in between.

Modern operational definition (what matters clinically)

  • Convulsive SE: seizure lasting 5\ge 5 minutes or recurrent seizures without regaining consciousness.
  • Nonconvulsive SE: altered mental status with ongoing electrographic seizures; often considered persistent 10\ge 10 minutes, but in practice: suspect early and confirm with EEG.

Classic definition (still tested)

  • Seizure activity 30\ge 30 minutes or repeated seizures without return to baseline.
    Why the newer 55-minute cut-off? Because after ~55 minutes, seizures are less likely to stop spontaneously and neuronal injury risk rises.

High-yield Step phrasing:

💡

“Generalized tonic-clonic seizure lasting 7 minutes” = status epilepticus until proven otherwise.


Why Status Epilepticus Becomes Self-Sustaining (Pathophysiology)

Core mechanism: shifting receptor biology during ongoing seizures

As seizure activity persists:

  • GABA-A receptors internalizebenzodiazepines become less effective over time
  • NMDA receptor activity increasesexcitotoxicity
  • Metabolic demand skyrockets → hypoxia, lactic acidosis, hyperthermia, rhabdomyolysis
  • Autonomic surge → tachycardia, hypertension early; hypotension later (especially after sedation)

Cellular injury (Step 1 angle)

  • Excess glutamate → increased intracellular Ca2+Ca^{2+}neuronal death
  • Hippocampal vulnerability is a classic association in prolonged seizures.

Key takeaway: Treat early—the first few minutes are the “benzodiazepine window.”


Etiologies & High-Yield Associations (Most Common Causes)

Think: breakthrough seizure in epilepsy, medication/nonadherence, metabolic, toxic, CNS catastrophe.

Common triggers to memorize

  • Antiepileptic drug (AED) nonadherence (very common)
  • Alcohol withdrawal (typically 6–48 hours after last drink)
  • Hypoglycemia
  • Hyponatremia (also other electrolyte derangements: Ca2+Ca^{2+}, Mg2+Mg^{2+})
  • Stroke/ICH, CNS infection, tumor, trauma
  • Toxin/drug-induced
    • Isoniazid (INH) → seizures from ↓ GABA synthesis (↓ pyridoxine)
      • Antidote: pyridoxine (vitamin B6)
    • Bupropion, tramadol, cocaine/amphetamines
  • Eclampsia (pregnancy + seizures) → treat with magnesium sulfate

“Don’t-miss” Step associations

  • Febrile seizures (kids) are usually benign, but prolonged febrile seizure can become SE.
  • HSV encephalitis (temporal lobe) can present with seizures/AMS → treat with acyclovir.

Clinical Presentation: Convulsive vs Nonconvulsive

Convulsive status epilepticus (CSE)

  • Overt tonic-clonic activity > 5 minutes
  • May start as focal seizure with secondary generalization
  • Postictal state may be absent because they never return to baseline

Complications to anticipate

  • Hypoxia, aspiration
  • Hyperthermia
  • Rhabdomyolysis → ↑ CK, AKI, hyperkalemia
  • Lactic acidosis

Nonconvulsive status epilepticus (NCSE)

Often tested as:

  • Persistent altered mental status, confusion, agitation, subtle twitching (eyelids, facial), nystagmus, automatisms
  • Post-convulsive state that doesn’t clear (patient remains “postictal” too long)

Exam clue: “Still not waking up 30–60 minutes after a seizure + vitals stabilized” → get EEG.


Diagnosis: What to Do While Treating

Status epilepticus is a clinical diagnosis, and treatment should not wait for confirmatory tests.

Immediate bedside priorities (ABCs)

  • Airway (consider early intubation if ongoing convulsions or depressed mental status)
  • Oxygen, suction, monitoring
  • IV access (often 2 lines)
  • Check point-of-care glucose (give dextrose if low; consider thiamine in malnourished/alcohol use)

Key labs and tests

TestWhy it matters
POC glucoseCorrect hypoglycemia immediately
CMP (Na, Ca, Mg), BUN/CrElectrolyte triggers; renal function for dosing
CBC, cultures if febrileInfection/meningitis/encephalitis
AED levels (if applicable)Nonadherence or subtherapeutic levels
Tox screenStimulants, INH, etc.
ABG/VBG, lactateAcidosis severity
CK, urinalysisRhabdomyolysis
ECGQRS/QT issues; tox clues
EEGEssential for NCSE and refractory cases
Head CT (noncontrast)Rule out bleed/mass if new focal deficits, trauma, first seizure, immunocompromised

Lumbar puncture: if you suspect CNS infection and imaging doesn’t contraindicate it—but don’t delay seizure control.


Treatment Algorithm (The USMLE-Friendly Flow)

This is the money section. The most testable pattern is:
Benzodiazepine → longer-acting AED → refractory anesthesia + ICU + EEG.

Step 0: Stabilize + “reversible causes”

  • ABCs, oxygen, cardiac monitor
  • Glucose: give dextrose if low
  • Consider thiamine before glucose in malnourished/alcohol use (classic Step association)
  • Correct electrolytes as needed

Step 1 (First-line): Benzodiazepine (fastest way to stop seizures)

Preferred options

  • Lorazepam IV (often preferred due to longer CNS duration)
  • Diazepam IV (rapid onset, shorter CNS duration)
  • Midazolam IM/IN if no IV access

Mechanism (First Aid cross-reference)
Benzos increase frequency of GABA-A opening → ↑ ClCl^{-} influx → neuronal inhibition.

High-yield nuance: Effectiveness declines as SE persists due to GABA-A receptor internalization.


Step 2 (Second-line): “Load” a longer-acting antiseizure med

Common choices:

  • Fosphenytoin/phenytoin
  • Valproate
  • Levetiracetam

Fosphenytoin/Phenytoin (classic board favorite)

  • MOA: blocks voltage-gated Na+ channels (stabilizes inactivated state)
  • Key adverse effects (Phenytoin — First Aid staples):
    • Nystagmus, ataxia, diplopia
    • Gingival hyperplasia
    • Hirsutism
    • Megaloblastic anemia (↓ folate)
    • Osteopenia (CYP induction → ↑ vitamin D metabolism)
    • Teratogenic (fetal hydantoin)
    • SJS/TEN risk (esp. certain HLA types)
  • Fosphenytoin: fewer infusion reactions than phenytoin

Valproate (great option in some patients)

  • MOA: ↑ GABA (inhibits degradation), blocks Na+ channels
  • AEs: hepatotoxicity, pancreatitis, neural tube defects, thrombocytopenia

Levetiracetam

  • MOA: SV2A modulation (synaptic vesicle protein)
  • AEs: mood changes/irritability (generally well tolerated)

Step pattern: If benzo stops the convulsions, you still need a loading AED to prevent recurrence.


Step 3: Refractory Status Epilepticus (ICU + continuous EEG)

Refractory SE = persists despite benzo + second-line AED.

Treatment:

  • Intubate + continuous EEG
  • Continuous infusion anesthetic (typical options):
    • Midazolam
    • Propofol
    • Barbiturate (pentobarbital)

Propofol warning (Step 2-style ICU pearl):

  • Propofol infusion syndrome (rare but deadly): metabolic acidosis, rhabdo, cardiac failure.

Nonconvulsive status often lives here: patient looks “quiet,” but EEG shows persistent seizure activity → treat like SE.


Special Scenarios You Should Recognize

INH-induced seizures

  • Cause: ↓ pyridoxine → ↓ GABA
  • Treat: benzodiazepines + pyridoxine (B6)

Eclampsia

  • Treat seizures: magnesium sulfate
  • Definitive: delivery
  • Beware: magnesium toxicity (loss of DTRs, respiratory depression)

Alcohol withdrawal seizures

  • First-line: benzodiazepines
  • Prevent: thiamine, fluids, treat autonomic instability; consider ICU if severe.

High-Yield “How They’ll Ask It” Vignettes

1) “5 minutes is the cutoff”

A patient has generalized tonic-clonic movements for 6 minutes → treat as SE with IV benzo immediately.

2) “Postictal too long” = consider NCSE

Patient had a convulsive seizure, now no longer convulsing but remains unresponsive 45 minutes later → EEG and treat for NCSE if confirmed.

3) “Benzo then phenytoin”

They’ll often ask: after lorazepam, what next?
Answer: fosphenytoin/phenytoin (or valproate/levetiracetam).

4) “Prevent complications”

Long convulsive seizure + dark urine + very high CK → rhabdo → aggressive IV fluids, monitor electrolytes.


First Aid Cross-References (Where This Lives in FA)

Use these as anchor points when you review:

  • GABA-A pharmacology: benzodiazepines (↑ frequency), barbiturates (↑ duration)
  • Phenytoin: Na+ channel blockade + classic toxicity list (nystagmus, ataxia, gingival hyperplasia, hirsutism, megaloblastic anemia, osteopenia, teratogen, SJS)
  • Valproate: hepatotoxicity, pancreatitis, neural tube defects
  • INH toxicity: seizures treated with pyridoxine
  • Alcohol withdrawal: benzos
  • Eclampsia: magnesium sulfate

(Edition page numbers vary, so use the index for: “status epilepticus,” “phenytoin,” “benzodiazepines,” “isoniazid,” “eclampsia.”)


Rapid-Fire Review (Exam-Day Bullets)

  • SE = 5\ge 5 min convulsive seizure or recurrent seizures without regaining baseline.
  • First-line: benzodiazepine (lorazepam IV; midazolam IM if no access).
  • Second-line: load fosphenytoin/phenytoin, valproate, or levetiracetam.
  • If ongoing: refractory SE → ICU, intubate, continuous EEG, anesthesia (propofol/midazolam/pentobarbital).
  • NCSE = altered mental status + seizure on EEG—don’t miss it.
  • Correct glucose/electrolytes, consider toxins (INH → B6).
  • Complications: hypoxia, aspiration, acidosis, hyperthermia, rhabdo.